• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于生物医学应用的基于癌细胞膜的纳米颗粒的最新进展。

Recent progress in cancer cell membrane-based nanoparticles for biomedical applications.

作者信息

Lin Qixiong, Peng Yueyou, Wen Yanyan, Li Xiaoqiong, Du Donglian, Dai Weibin, Tian Wei, Meng Yanfeng

机构信息

The Ninth Clinical Medical School of Shanxi Medical University, Taiyuan, Shanxi 030009, China.

Department of MRI, Taiyuan Central Hospital of Shanxi Medical University, Taiyuan, Shanxi 030009, China.

出版信息

Beilstein J Nanotechnol. 2023 Feb 27;14:262-279. doi: 10.3762/bjnano.14.24. eCollection 2023.

DOI:10.3762/bjnano.14.24
PMID:36895440
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9989677/
Abstract

Immune clearance and insufficient targeting have limited the efficacy of existing therapeutic strategies for cancer. Toxic side effects and individual differences in response to treatment have further limited the benefits of clinical treatment for patients. Biomimetic cancer cell membrane-based nanotechnology has provided a new approach for biomedicine to overcome these obstacles. Biomimetic nanoparticles exhibit various effects (e.g., homotypic targeting, prolonging drug circulation, regulating the immune system, and penetrating biological barriers) after encapsulation by cancer cell membranes. The sensitivity and specificity of diagnostic methods will also be improved by utilizing the properties of cancer cell membranes. In this review, different properties and functions of cancer cell membranes are presented. Utilizing these advantages, nanoparticles can exhibit unique therapeutic capabilities in various types of diseases, such as solid tumors, hematological malignancies, immune system diseases, and cardiovascular diseases. Furthermore, cancer cell membrane-encapsulated nanoparticles show improved effectiveness and efficiency in combination with current diagnostic and therapeutic methods, which will contribute to the development of individualized treatments. This strategy has promising clinical translation prospects, and the associated challenges are discussed.

摘要

免疫清除和靶向不足限制了现有癌症治疗策略的疗效。毒性副作用以及个体对治疗反应的差异进一步限制了临床治疗给患者带来的益处。基于仿生癌细胞膜的纳米技术为生物医学克服这些障碍提供了一种新方法。仿生纳米颗粒在被癌细胞膜包裹后展现出多种效应(如同源靶向、延长药物循环时间、调节免疫系统以及穿透生物屏障)。利用癌细胞膜的特性还能提高诊断方法的灵敏度和特异性。在这篇综述中,介绍了癌细胞膜的不同特性和功能。利用这些优势,纳米颗粒在各类疾病(如实体瘤、血液系统恶性肿瘤、免疫系统疾病和心血管疾病)中可展现出独特的治疗能力。此外,与当前的诊断和治疗方法相结合时,癌细胞膜包裹的纳米颗粒显示出更高的有效性和效率,这将有助于个性化治疗的发展。这种策略具有广阔的临床转化前景,并对相关挑战进行了讨论。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/080f/9989677/43c19be9a483/Beilstein_J_Nanotechnol-14-262-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/080f/9989677/035f53016498/Beilstein_J_Nanotechnol-14-262-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/080f/9989677/8dab04720f7c/Beilstein_J_Nanotechnol-14-262-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/080f/9989677/0d29a9ee8fdf/Beilstein_J_Nanotechnol-14-262-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/080f/9989677/017bb2f02f70/Beilstein_J_Nanotechnol-14-262-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/080f/9989677/e6aeacbaeb61/Beilstein_J_Nanotechnol-14-262-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/080f/9989677/66b3f2952853/Beilstein_J_Nanotechnol-14-262-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/080f/9989677/43c19be9a483/Beilstein_J_Nanotechnol-14-262-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/080f/9989677/035f53016498/Beilstein_J_Nanotechnol-14-262-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/080f/9989677/8dab04720f7c/Beilstein_J_Nanotechnol-14-262-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/080f/9989677/0d29a9ee8fdf/Beilstein_J_Nanotechnol-14-262-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/080f/9989677/017bb2f02f70/Beilstein_J_Nanotechnol-14-262-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/080f/9989677/e6aeacbaeb61/Beilstein_J_Nanotechnol-14-262-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/080f/9989677/66b3f2952853/Beilstein_J_Nanotechnol-14-262-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/080f/9989677/43c19be9a483/Beilstein_J_Nanotechnol-14-262-g008.jpg

相似文献

1
Recent progress in cancer cell membrane-based nanoparticles for biomedical applications.用于生物医学应用的基于癌细胞膜的纳米颗粒的最新进展。
Beilstein J Nanotechnol. 2023 Feb 27;14:262-279. doi: 10.3762/bjnano.14.24. eCollection 2023.
2
Hybrid cell membrane-coated nanoparticles: A multifunctional biomimetic platform for cancer diagnosis and therapy.混合细胞膜包覆纳米颗粒:用于癌症诊断与治疗的多功能仿生平台。
Acta Biomater. 2020 Aug;112:1-13. doi: 10.1016/j.actbio.2020.05.028. Epub 2020 May 26.
3
Stem cell membrane, stem cell-derived exosomes and hybrid stem cell camouflaged nanoparticles: A promising biomimetic nanoplatforms for cancer theranostics.干细胞膜、干细胞衍生的外泌体和杂交干细胞伪装纳米颗粒:一种有前途的仿生纳米平台,用于癌症治疗和诊断。
J Control Release. 2022 Aug;348:706-722. doi: 10.1016/j.jconrel.2022.06.026. Epub 2022 Jun 22.
4
Stem cell membrane-coated abiotic nanomaterials for biomedical applications.用于生物医学应用的干细胞膜包覆的非生物纳米材料。
J Control Release. 2022 Nov;351:174-197. doi: 10.1016/j.jconrel.2022.09.012. Epub 2022 Sep 22.
5
Construction of Biomimetic-Responsive Nanocarriers and their Applications in Tumor Targeting.仿生响应型纳米载体的构建及其在肿瘤靶向中的应用。
Anticancer Agents Med Chem. 2022;22(12):2255-2273. doi: 10.2174/1871520622666220106105315.
6
Biomimetic hybrid membrane-based nanoplatforms: synthesis, properties and biomedical applications.仿生杂化膜基纳米平台:合成、性质及生物医学应用。
Nanoscale Horiz. 2020 Sep 1;5(9):1293-1302. doi: 10.1039/d0nh00267d. Epub 2020 Jul 1.
7
Immune Cell Membrane-Coated Biomimetic Nanoparticles for Targeted Cancer Therapy.免疫细胞膜包覆仿生纳米颗粒用于靶向癌症治疗。
Small. 2021 Mar;17(12):e2006484. doi: 10.1002/smll.202006484. Epub 2021 Feb 12.
8
Hybrid Membrane-Coated Biomimetic Nanoparticles (HM@BNPs): A Multifunctional Nanomaterial for Biomedical Applications.杂化膜包覆仿生纳米粒子 (HM@BNPs):一种用于生物医学应用的多功能纳米材料。
Biomacromolecules. 2021 Aug 9;22(8):3149-3167. doi: 10.1021/acs.biomac.1c00440. Epub 2021 Jul 6.
9
Recent Advances in Cell Membrane-Derived Biomimetic Nanotechnology for Cancer Immunotherapy.用于癌症免疫治疗的细胞膜衍生仿生纳米技术的最新进展
Adv Healthc Mater. 2021 Mar;10(6):e2002081. doi: 10.1002/adhm.202002081. Epub 2021 Feb 15.
10
Biomimetic Targeted Theranostic Nanoparticles for Breast Cancer Treatment.仿生靶向治疗乳腺癌的纳米粒子。
Molecules. 2022 Oct 1;27(19):6473. doi: 10.3390/molecules27196473.

引用本文的文献

1
Application of nanomedicines in tumor immunotherapy.纳米药物在肿瘤免疫治疗中的应用。
J Mol Cell Biol. 2025 Jun 12;16(12). doi: 10.1093/jmcb/mjae055.
2
Carcinomembrane-Camouflaged Perfluorochemical Dual-Layer Nanopolymersomes Bearing Indocyanine Green and Camptothecin Effectuate Targeting Photochemotherapy of Cancer.载吲哚菁绿和喜树碱的癌膜伪装型氟碳双层纳米聚合物囊用于癌症靶向光化疗。
ACS Biomater Sci Eng. 2024 Oct 14;10(10):6332-6343. doi: 10.1021/acsbiomaterials.4c01150. Epub 2024 Sep 12.
3
Iron Oxide Nanoparticles: Parameters for Optimized Photoconversion Efficiency in Synergistic Cancer Treatment.

本文引用的文献

1
Triple-negative breast cancer drug resistance, durable efficacy, and cure: how advanced biological insights and emerging drug modalities could transform progress.三阴性乳腺癌的耐药性、持久疗效与治愈:先进生物学见解和新兴药物模式如何推动进展。
Expert Opin Ther Targets. 2022 Jun;26(6):513-535. doi: 10.1080/14728222.2022.2094762. Epub 2022 Jul 6.
2
Bioactive cytomembrane@poly(citrate-peptide)-miRNA365 nanoplatform with immune escape and homologous targeting for colon cancer therapy.具有免疫逃逸和同源靶向功能的生物活性细胞膜@聚(柠檬酸-肽)-miRNA365纳米平台用于结肠癌治疗。
Mater Today Bio. 2022 May 17;15:100294. doi: 10.1016/j.mtbio.2022.100294. eCollection 2022 Jun.
3
氧化铁纳米颗粒:协同癌症治疗中优化光转换效率的参数
J Funct Biomater. 2024 Jul 25;15(8):207. doi: 10.3390/jfb15080207.
4
Recent updates in applications of nanomedicine for the treatment of hepatic fibrosis.纳米医学在肝纤维化治疗中的应用的最新进展。
Beilstein J Nanotechnol. 2024 Aug 23;15:1105-1116. doi: 10.3762/bjnano.15.89. eCollection 2024.
5
Multistage Self-Assembled Nanomaterials for Cancer Immunotherapy.多级自组装纳米材料用于癌症免疫治疗。
Molecules. 2023 Nov 24;28(23):7750. doi: 10.3390/molecules28237750.
6
New insights into nanosystems for non-small-cell lung cancer: diagnosis and treatment.非小细胞肺癌纳米系统的新见解:诊断与治疗
RSC Adv. 2023 Jun 28;13(28):19540-19564. doi: 10.1039/d3ra03099g. eCollection 2023 Jun 22.
Enhancement of antitumor immunotherapy using mitochondria-targeted cancer cell membrane-biomimetic MOF-mediated sonodynamic therapy and checkpoint blockade immunotherapy.
利用靶向线粒体的癌细胞膜仿生 MOF 介导的声动力学疗法和检查点阻断免疫疗法增强抗肿瘤免疫治疗。
J Nanobiotechnology. 2022 May 14;20(1):228. doi: 10.1186/s12951-022-01453-2.
4
Biomimetic nanoparticles for effective mild temperature photothermal therapy and multimodal imaging.用于有效温和温度光热治疗和多模式成像的仿生纳米颗粒。
J Control Release. 2022 Jul;347:270-281. doi: 10.1016/j.jconrel.2022.05.010. Epub 2022 May 13.
5
Engineered PD-1/TIGIT dual-activating cell-membrane nanoparticles with dexamethasone act synergistically to shape the effector T cell/Treg balance and alleviate systemic lupus erythematosus.载有地塞米松的 PD-1/TIGIT 双激活细胞膜纳米颗粒通过协同作用来调节效应 T 细胞/Treg 平衡,从而缓解系统性红斑狼疮。
Biomaterials. 2022 Jun;285:121517. doi: 10.1016/j.biomaterials.2022.121517. Epub 2022 Apr 25.
6
Advancements in cell membrane camouflaged nanoparticles: A bioinspired platform for cancer therapy.细胞膜伪装纳米颗粒的进展:癌症治疗的仿生平台。
J Control Release. 2022 Jun;346:71-97. doi: 10.1016/j.jconrel.2022.04.019. Epub 2022 Apr 21.
7
Dissolving microneedles delivering cancer cell membrane coated nanoparticles for cancer immunotherapy.用于癌症免疫治疗的递送癌细胞膜包被纳米颗粒的可溶解微针
RSC Adv. 2021 Mar 11;11(17):10393-10399. doi: 10.1039/d1ra00747e. eCollection 2021 Mar 5.
8
Targeted delivery of a PROTAC induced PDEδ degrader by a biomimetic drug delivery system for enhanced cytotoxicity against pancreatic cancer cells.通过仿生药物递送系统靶向递送PROTAC诱导的PDEδ降解剂以增强对胰腺癌细胞的细胞毒性。
Am J Cancer Res. 2022 Mar 15;12(3):1027-1041. eCollection 2022.
9
CRPC Membrane-Camouflaged, Biomimetic Nanosystem for Overcoming Castration-Resistant Prostate Cancer by Cellular Vehicle-Aided Tumor Targeting.基于细胞载体靶向肿瘤的克服去势抵抗性前列腺癌的伪装膜仿生纳米系统
Int J Mol Sci. 2022 Mar 26;23(7):3623. doi: 10.3390/ijms23073623.
10
Tumor cell membrane-camouflaged responsive nanoparticles enable MRI-guided immuno-chemodynamic therapy of orthotopic osteosarcoma.肿瘤细胞膜伪装的响应性纳米颗粒实现原位骨肉瘤的磁共振成像引导免疫化学动力学治疗。
Bioact Mater. 2022 Jan 26;17:221-233. doi: 10.1016/j.bioactmat.2022.01.035. eCollection 2022 Nov.